Group | Test Period | Constant Power Test | UBP10 Test Trial #1 | UBP10 Test Trial #2 | UBP10 Test Trial #3 | UBP60 Test |
---|---|---|---|---|---|---|
Placebo (n = 12) | Pre-Test | 100.6 ± 11.5 | 87.9 ± 10.0 | 99.4 ± 10.2 | 110.4 ± 9.4 | 147.2 ± 12.1 |
Post-Test | 100.7 ± 13.2 | 92.3 ± 9.9 | 109.8 ± 9.9 | 113.9 ± 10.1 | 148.6 ± 13.2 | |
Treatment (n = 12) | Pre-Test | 104.6 ± 11.7 | 102.9 ± 7.7 | 126.0 ± 12.8 | 129.7 ± 10.3 | 163.5 ± 12.0 |
Post-Test | 101.7 ± 10.6 | 97.3 ± 9.8 | 122.4 ± 11.8 | 132.1 ± 12.9 | †153.3 ± 11.1 |